Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 28, 2016; 22(48): 10631-10642
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10631
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10631
n | Change to optimal from constipation or diarrhea | Change to constipation or diarrhea from optimal | |
Placebo | 131 | ||
Week 4 | 18 (13.7) | 15 (11.5) | |
Week 12 | 21 (16.0) | 18 (13.7) | |
Washout | 20 (15.3) | 17 (13.0) | |
Low-dose | 129 | ||
Week 4 | 26 (20.2) | 13 (10.1) | |
Week 12 | 27 (20.9) | 14 (10.9) | |
Washout | 14 (10.9) | 12 (9.3) | |
High-dose | 131 | ||
Week 4 | 14 (10.7) | 16 (12.2) | |
Week 12 | 18 (13.7) | 20 (15.3) | |
Washout | 14 (10.7) | 18 (13.7) | |
Total | 391 | 172 (44.0) | 143 (36.6) |
- Citation: Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22(48): 10631-10642
- URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10631